About DxGen
DxGen is a company based in Gunpo (South Korea) founded in 2016. DxGen offers products and services including Epithod® 616 Analyzer, HbA1c Test Kit, CRP Test Kit, AUTODX, and MINI BIOSCIENCE. DxGen operates in a competitive market with competitors including SD Biosensor, Access Bio, Lumos Diagnostics, 1Drop Diagnostics and Fluxergy, among others.
- Headquarter Gunpo, South Korea
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name (주)딕스젠 Dxgen Corp
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DxGen
DxGen offers a comprehensive portfolio of products and services, including Epithod® 616 Analyzer, HbA1c Test Kit, CRP Test Kit, AUTODX, and MINI BIOSCIENCE.
Reliable system for diabetes and infectious disease testing.
Determines Glycated Hemoglobin levels in human blood.
Measures C-reactive protein in blood for diagnostics.
System for HbA1c and other biomarker testing.
Provides tools for biomarker analysis and diagnostics.
Funding Insights of DxGen
Detailed funding history for DxGen
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DxGen
Investment portfolio details for DxGen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DxGen
Detailed financials for DxGen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dxgen Comparisons
Peer comparison for DxGen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DxGen
DxGen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SD Biosensor, Access Bio, Lumos Diagnostics, 1Drop Diagnostics and Fluxergy, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biosensors for point-of-care diagnostics are developed by SD Biosensor.
|
|
| Locked | Locked | Locked |
In vitro rapid diagnostic tests, biosensor, and molecular diagnostic products for diagnosis of infectious diseases.
|
|
| Locked | Locked | Locked |
Diversified diagnostic assays and readers are developed for point-of-care use.
|
|
| Locked | Locked | Locked |
Finger-prick point-of-care diagnostics are provided for biomarker testing.
|
|
| Locked | Locked | Locked |
Provides diagnostic devices and software for clinical and veterinary point-of-care testing.
|
|
| Locked | Locked | Locked |
Point-of-care tests for diabetes and women's health risks are developed.
|
Detailed competitors of DxGen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dxgen
Complete news archive for DxGen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DxGen
DxGen was founded in 2016.
DxGen is headquartered in Gunpo, South Korea. It is registered at Gunpo, Gyeonggi, South Korea.
DxGen was founded in 2016 and operates in the healthcare diagnostics sector. Point-of-care analyzers and test kits are supplied for diabetes management, covering stages from initial assessment to post-diagnosis treatment. Measurements include HbA1c, glycated albumin, CRP, hemoglobin, micro-albumin, and tuberculosis markers. Multi-marker diagnostic devices for diabetes and tuberculosis patients are under development.
DxGen's top competitors include Access Bio, SD Biosensor and Lumos Diagnostics.
DxGen offers Epithod® 616 Analyzer, HbA1c Test Kit, CRP Test Kit, AUTODX, and MINI BIOSCIENCE.